LDN - Other News

World stocks head for record high on recovery, vaccine hopes

[November 16, 2020] By Simon Jessop and Tom Westbrook

LONDON/SYDNEY (Reuters) - Global stocks eyed a fresh record high on Monday as signs of economic recovery in Asia, recent strong corporate earnings and hopes of a COVID-19 vaccine bolstered investor sentiment.

The MSCI World Index of global shares rose 0.5% to 608.79 points, just shy of the record high hit briefly earlier in the month, helped by strong overnight gains in Asia's leading markets and a stronger open for most European bourses.

MSCI's broadest index of Asia-Pacific shares outside Japan hit its highest level since launching in 1987 as Japan pulled out of recession, China posted better-than-expected industrial output data and the region signed the largest ever trade deal.

Taking their lead, European indices also rose with Britain's FTSE 100 <.FTSE> and the pan-Europe STOXX Europe 600 <.STOXX> both up around 0.7%.

"The markets get the new trading week off to a solid start, which is encouraging given all the excitement generated in the last seven days by news of vaccine breakthroughs," said AJ Bell investment director Russ Mould.

"Solid and steady gains are arguably just what investors need after a very volatile period."

U.S. stock futures in turn pointed to a positive start for Wall Street later in the day.

"With the futures pencilling in a 300-point rise, the Dow is set to start the week at 29,770, finally making good on the all-time high intraday levels struck this time last week," said Connor Campbell, financial analyst at Spreadex.

The prospect of economic recovery also helped oil prices strengthen, with both Brent crude futures and West Texas Intermediate up around 0.8%, just off their intraday highs.

Amid all the optimism, European government bond yields also fell back with Italian benchmark 10-year yields down 3 basis points.

Not every asset was swept up by the rising tide, however, with the dollar flat against a basket of currencies, weighed down by fresh data over the weekend showing an increase in the number of COVID-19 cases.

Gold steadied near a one-week high, up 0.3% at $1,893 an ounce.

While rising cases of the coronavirus were a risk, Morgan Stanley strategists urged investors to "keep the faith" in their 2021 outlook note.

"We think this global recovery is sustainable, synchronous and supported by policy, following much of the 'normal' post-recession playbook. Overweight equities and credit against cash and government bonds, and sell dollars."

[to top of second column]

Passersby wearing protective face masks walk past a screen displaying Nikkei share average and world stock indexes outside a brokerage, amid the coronavirus disease (COVID-19) outbreak, in Tokyo, Japan October 5, 2020. REUTERS/Issei Kato

For stocks, the analysts see earnings-per-share growth of between 25% and 30% across regions, with double-digit total returns through the end of 2021 that should helped power the S&P 500 to 3,900 points from its current 3,585 points.

ASIA MARCHES ON

The announcement, a week ago, that Pfizer <PFE.N> had developed a very effective vaccine has investors hoping for similar good news soon from rival Moderna <MRNA.O> and looking past a tough winter to a better spring and summer ahead.

Besides the virus, Brexit trade talks were chief among European investors' concerns on Monday, with hopes for a breakthrough ebbing slightly to leave sterling weaker against the dollar and the euro.

The British pound gave up early gains to edge lower against the dollar <GBP=D3>, changing hands at 1.3176 per dollar, and against the common currency as well, and last stood at 89.90 pence per euro <EURGBP=D3>.

While the departure of hardline adviser Dominic Cummings from Downing Street is seen as a positive, perhaps allowing more British concessions, the UK's chief Brexit negotiator David Frost said on Twitter that talks "may not succeed".

A slew of U.S. Federal Reserve speakers are also up this week, beginning with Vice Chair Richard Clarida at 1900 GMT.

U.S. bonds, which had sold off strongly on vaccine news last week, were again slightly lower, with the yield on benchmark U.S. 10-year debt at 0.8799%.

(Editing by Richard Pullin, Raissa Kasolowsky and Susan Fenton)

Back to top